Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mural Oncology plc - Ordinary Shares (NQ: MURA ) 3.280 -0.010 (-0.30%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 57,115 Open 3.290 Bid (Size) 3.410 (5) Ask (Size) 3.950 (2) Prev. Close 3.290 Today's Range 3.234 - 3.320 52wk Range 2.880 - 17.00 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News MURA Stock Earnings: Mural Oncology Beats EPS for Q2 2024 August 13, 2024 MURA stock results show that Mural Oncology beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progress August 13, 2024 From Mural Oncology, Inc. Via GlobeNewswire Performance YTD -45.15% -45.15% 1 Month -4.93% -4.93% 3 Month -8.64% -8.64% 6 Month -29.46% -29.46% 1 Year -13.68% -13.68% More News Read More Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 02, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its Board of Directors July 31, 2024 From Mural Oncology, Inc. Via GlobeNewswire MURA Stock Earnings: Mural Oncology Reported Results for Q1 2024 May 14, 2024 Via InvestorPlace MURA Stock Earnings: Mural Oncology Reported Results for Q4 2023 March 26, 2024 Via InvestorPlace Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural to Present and Host 1x1 Investor Meetings at the 14th Annual East Coast IDEAS Investor Conference June 05, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Mural Oncology, Inc. Via GlobeNewswire MURA Stock Earnings: Mural Oncology Reported Results for Q3 2023 December 18, 2023 Via InvestorPlace Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting May 23, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Announces Upcoming Presentation at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting April 09, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 04, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Update March 26, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Announces Upcoming Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting March 05, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 04, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology to Present at the TD Cowen 44th Annual Health Care Conference February 27, 2024 From Mural Oncology, Inc. Via GlobeNewswire Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 05, 2024 From Mural Oncology, Inc. Via GlobeNewswire The 3 Best Biotech Stocks to Invest in for Big Gains in 2024 February 02, 2024 Via InvestorPlace The 3 Most Undervalued Biotech Stocks to Buy in January January 15, 2024 Via InvestorPlace Mural Oncology Announces Enhancements to Late-Stage Clinical Trials January 08, 2024 From Mural Oncology, Inc. Via GlobeNewswire Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket November 20, 2023 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
